These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria? Zhu JN, Nie LY, Lu XY, Wu HX. Clin Chem Lab Med; 2019 Oct 25; 57(11):1668-1679. PubMed ID: 31141478 [Abstract] [Full Text] [Related]
51. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Kwok JS, Hui KH, Lee TL, Wong W, Lau YL, Wong RW, Kim DL, Jones BM. Scand J Rheumatol; 2005 Oct 25; 34(5):359-66. PubMed ID: 16234183 [Abstract] [Full Text] [Related]
53. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Kasapçopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Göksel A, Saribas S, Arisoy N, Kocazeybek B. Ann Rheum Dis; 2004 Dec 25; 63(12):1687-9. PubMed ID: 15547097 [Abstract] [Full Text] [Related]
54. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families. Kim SK, Bae J, Lee H, Kim JH, Park SH, Choe JY. Korean J Intern Med; 2013 Jan 25; 28(1):45-53. PubMed ID: 23345996 [Abstract] [Full Text] [Related]
57. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Ménard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, le Loët X, Tron F. Clin Exp Immunol; 2004 Jan 25; 135(1):173-80. PubMed ID: 14678280 [Abstract] [Full Text] [Related]